FDA NDC Directory · JSON-LD · Markdown

Fondaparinux Sodium

NDC 0781-3443 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerSandoz Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA206812
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsFONDAPARINUX SODIUM (2.5 mg/.5mL)
Marketing started20190618
Package count2

External sources

Source: openFDA. Public-domain (CC0).